Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)
Clinical trial NCT04223752 · COMPLETED
Trial details
- NCT number
- NCT04223752
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-17
- Primary completion
- 2024-09-14
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.